Jeff brings to Expression Analysis (EA) over a decade of successful sales and support experience with Affymetrix and RainDance Technologies.
While at RainDance, Jeff cultivated new business opportunities in research and clinical markets through the use of its sequence enrichment solutions in conjunction with various next generation sequencing platforms.
During his sales role at Affymetrix, he supported key genome and academic research centers in the use of expression, resequencing, and genotyping microarrays.
Prior to his commercial experience, Jeff sought to identify molecular markers responsible for tumor progression while performing research in the Department of Pathology at Brigham and Women’s Hospital and Harvard Medical School.
Jeff received his Bachelor of Science degree in Microbiology and Molecular Genetics from the University of Vermont.
“We are very pleased to have Jeff join us here at EA,” says Steve McPhail, CEO and President of Expression Analysis. “His experience and wealth of knowledge will greatly benefit the company as we continue to expand our services and customer base.”